Saskia De Haes brings more than 27 years of pharmaceutical industry experience of which the vast majority with Johnson & Johnson. She worked in Pharmaceutical & Analytical Development, Supply chain, Project Management and in Global Regulatory Affairs and held seats in multiple senior leadership teams in R&D as well as the commercial organization.
Since June 2020, Saskia is the Vice President Regulatory Affairs EMEA (Europe, Middle East and Africa) for Janssen where she is responsible for all Regulatory activities in the EMEA region for the entire Janssen portfolio.
Prior to this role, Saskia held the position of Vice President Global Regulatory Affairs Janssen for the Pulmonary Hypertension Therapeutic Area. In this role, she was responsible for worldwide Regulatory Affairs strategy and execution for this Therapeutic Area.
Other key roles Saskia held in the past relate to leading business improvement programs spanning across multiple functions within Johnson & Johnson and Senior Director EMEA Regulatory Affairs for Infectious Diseases & Vaccines where she contributed substantially to the EMEA approvals for multiple key brands. Earlier in her career, Saskia served as Global Regulatory Leader for Infectious Diseases drugs in early development and as CMC project leader for HIV drugs. Saskia also held global Project Management roles and CMC responsibilities within the Neuroscience Therapeutic Area.
Saskia is a member of multiple Janssen Senior Leadership teams both functionally and commercially, is a member of the Beerse campus Board of Directors and a member of EFPIA’s Regulatory Strategy Committee.
Saskia obtained her Pharmacy degree at the University of Ghent and she is a certified Industrial Pharmacist.
Saskia is passionate about art, music and travelling and loves to interact with people and learn about new cultures and new perspectives.